Feasibility Study of a Novel Single Use Robotic Colonoscopy System

NCT ID: NCT03979690

Last Updated: 2019-10-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-06-12

Study Completion Date

2019-09-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a single centre, non-randomized, tandem colonoscopy trial of the NISInspire-C System, followed immediately by a conventional colonoscope (CC). Each trial subject will undergo colonoscopy using the NISInspire-C system, followed immediately by CC. The purpose of this study is to obtain observational data on the safety profile, feasibility and usability of the NISInspire-C System in performing diagnostic colonoscopy in human subjects. The level of procedural pain experienced by subjects will also be explored.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colonic Polyp Colon Adenoma Colorectal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subjects Receiving Colonoscopy

Subjects receiving tandem colonoscopies using the NISInspire-C System followed by a Conventional Colonoscopy

Group Type EXPERIMENTAL

NISInspire-C System

Intervention Type DEVICE

The NISInspire-C System is a disposable robotic colonoscopy system that consists of a flexible slender insertion tube designed to ensure non-invasive, reliable and safe colorectal screening. It comprises of two components: NISInspire-C Console, and the NISInspire-C Disposable Colonoscope.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NISInspire-C System

The NISInspire-C System is a disposable robotic colonoscopy system that consists of a flexible slender insertion tube designed to ensure non-invasive, reliable and safe colorectal screening. It comprises of two components: NISInspire-C Console, and the NISInspire-C Disposable Colonoscope.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males aged between 40 and 70 years, inclusive, at the time of informed consent
* Females aged between 55 and 70 years, inclusive, at the time of informed consent (Rationale: to include only women with non-childbearing potential to avoid completely pregnant trial subjects)
* Symptomatic adults indicated for elective colonoscopy, or asymptomatic adults willing to undergo a colonoscopic screening for polyps or colorectal cancer
* Adults without prior colonoscopy
* Able to provide a written informed consent form approved by an Independent Ethics Committee (IEC)/ Institutional Review Board (IRB), prior to any study-specific procedures
* Willing and able to comply with the study procedures

Exclusion Criteria

* History of colorectal cancer, inflammatory bowel disease, polyposis syndrome, familial polyposis coli, hereditary nonpolyposis colorectal cancer syndrome, active diverticulitis or toxic megacolon
* Lower gastrointestinal bleeding within 28 days prior to the colonoscopy day
* Known bleeding tendency
* Received antiplatelet or anticoagulation therapy within 3 days prior to the colonoscopy day
* Known colonic stricture
* Known multiple sigmoid colon diverticula
* History of any abdominal or pelvis surgical procedures including colonic and rectal surgical resection
* Known abdominal wall hernias
* History of radiotherapy to the abdomen or pelvis
* Known coronary ischemia or cardiovascular stroke within 3 months prior to the colonoscopy day
* Contraindication to the proposed anaesthesia
* Received any investigational medicine or treatment within 28 days prior to Screening
* Any condition, in the opinion of the Investigator, that is unstable and could jeopardize the safety of the subject and their compliance in the study
Minimum Eligible Age

40 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of Hong Kong

OTHER

Sponsor Role collaborator

Bio-Medical Engineering (HK) Limited

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wai Keung Leung, Professor

Role: PRINCIPAL_INVESTIGATOR

Division of Gastroenterology & Hepatology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital

Dominic Chi Chung Foo, Dr

Role: PRINCIPAL_INVESTIGATOR

Division of Colorectal Surgery, Department of Surgery, The University of Hong Kong, Queen Mary Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The University of Hong Kong, Queen Mary Hospital

Hong Kong, , Hong Kong

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hong Kong

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HKUCTR-2616

Identifier Type: REGISTRY

Identifier Source: secondary_id

HKUCTR-2617

Identifier Type: OTHER

Identifier Source: secondary_id

NISInspire-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.